Glasswing Ventures

Glasswing Ventures is a Boston-based early-stage venture firm with a thesis focused on AI-powered enterprise and security software, with portfolio depth in machine learning infrastructure, cybersecurity, and applied AI across vertical industries. The glasswing.vc website confirms an AI-native investing platform led by Rudina Seseri and a partner team with technical and operational backgrounds. For healthcare AI founders, Glasswing is a credible match for businesses where AI is the core technical wedge and the customer is enterprise: clinical decision support for hospital systems, AI-driven medical imaging, healthcare data security, healthcare workflow automation with strong ML defensibility, and AI infrastructure with healthcare applications. Plausible check sizes run 1M to 5M at seed and Series A, with selective follow-on. The firm leads or co-leads. Founders building consumer health, deep biotech, or services-heavy businesses without strong AI defensibility should look elsewhere; this is an enterprise AI investor, not a vertical healthcare specialist. Entry path is LinkedIn outreach to partners with a technically substantive pitch, or warm introduction through Boston AI operator networks, MIT and Harvard research circles, or other AI-focused investors. The firm reads inbound and responds to credible AI-native pitches. Diligence will be technically rigorous: expect engagement on model architecture, training data strategy, defensibility, and competitive moats against well-resourced incumbents. Bring your technical lead to the first meeting and prepared to defend why your AI approach is durable. The value-add includes AI operating expertise, enterprise customer introductions, and credible co-investor relationships. Glasswing rewards technical founders who can articulate AI defensibility precisely, not founders selling on market size or generic AI applicability.